Compare EVO & PDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVO | PDM |
|---|---|---|
| Founded | 1993 | 1997 |
| Country | Germany | United States |
| Employees | 4553 | 140 |
| Industry | Biotechnology: Pharmaceutical Preparations | Building operators |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 934.1M | 1.1B |
| IPO Year | N/A | 1997 |
| Metric | EVO | PDM |
|---|---|---|
| Price | $3.06 | $8.51 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | $7.00 | ★ $9.00 |
| AVG Volume (30 Days) | 95.4K | ★ 1.2M |
| Earning Date | 04-08-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $564,994,000.00 |
| Revenue This Year | $1.37 | $4.21 |
| Revenue Next Year | $10.05 | $1.29 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.31 | $6.32 |
| 52 Week High | $4.80 | $9.19 |
| Indicator | EVO | PDM |
|---|---|---|
| Relative Strength Index (RSI) | 52.19 | 68.05 |
| Support Level | $2.88 | $8.03 |
| Resistance Level | $3.78 | $8.79 |
| Average True Range (ATR) | 0.12 | 0.27 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 33.33 | 71.88 |
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
Piedmont Realty Trust Inc is a fully integrated, self-managed real estate investment company focused on delivering an exceptional office environment. As an owner, manager, developer and operator of 16 MM SF of Class A properties across U.S. Sunbelt markets, Piedmont Realty Trust is known for its hospitality-driven approach and commitment to transforming buildings into Piedmont PLACEs that enhance each client's workplace experience.